Pulmonary hypertension and exercise intolerance in patients with heart failure.

J Am Coll Cardiol

Division of Cardiology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.

Published: November 1999

Objectives: This study was undertaken to investigate the relationship between pulmonary hypertension and exercise performance in patients with heart failure.

Background: The exercise capacity of patients with heart failure is frequently reduced. Pulmonary hypertension may contribute to this exercise intolerance by impairing blood flow through the pulmonary circulation.

Method: Three hundred twenty patients with heart failure underwent upright treadmill exercise testing with hemodynamic monitoring. The incidence of pulmonary hypertension and the relationship between pulmonary vascular resistance (PVR) and exercise cardiac output and minute oxygen consumption (VO2) were examined.

Results: Pulmonary vascular resistance was normal (<1.5 Wood Units; Group 1) in 28% of the patients, mildly elevated (1.5 to 2.49 Wood Units; Group 2) in 36%, moderately elevated (2.5 to 3.49 Wood Units; Group 3) in 17% and severely elevated (>3.5 Wood Units; Group 4) in 19%. Increasing PVR was associated with significantly lower peak exercise VO2 (Group 1: 13.9+/-3.7; 2:13.7+/-3.4; 3: 11.8+/-2.4; 4: 11.5+/-2.6 L/min, p<0.01 Groups 3 and 4 vs. 1) and lower peak exercise cardiac output (Group 1: 10.0+/-2.8, 2:9.0+/-3.0; 3: 7.4+/-2.1; 4: 6.3+/-2.0 L/min, p<0.05, Groups 2, 3 and 4 vs. 1). The pulmonary wedge pressure decreased during exercise, consistent with impaired left ventricular filling, in 36% of patients with severe pulmonary hypertension (Group 4) versus only 13% of patients with normal PVR (p<0.01).

Conclusions: Pulmonary vascular resistance is frequently increased in heart failure and is associated with a reduced cardiac output response to exercise, suggesting that pulmonary hypertension impairs exercise performance in heart failure.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0735-1097(99)00408-8DOI Listing

Publication Analysis

Top Keywords

pulmonary hypertension
16
patients heart
16
heart failure
12
hypertension exercise
8
exercise intolerance
8
relationship pulmonary
8
pulmonary vascular
8
vascular resistance
8
pulmonary
7
exercise
7

Similar Publications

Background: Anastomotic leak after esophagectomy is a major cause of morbidity and mortality. We sought to identify the prevalence of anastomotic leak, stratified by operative approach and disease etiology, as well as risk factors for leak.

Methods: A retrospective cohort analysis using the STS General Thoracic Surgery Database was conducted on patients who underwent esophagectomy with gastric reconstruction between 2009-2021.

View Article and Find Full Text PDF

Pulmonary arterial hypertension (PAH) is a disease characterized by increased pulmonary vascular resistance and elevated pulmonary arterial pressure. Currently, pathogenesis of PAH remains poorly understood, and therapeutic options are limited. In this study, we aimed to explore role of p16INK4A (p16) in the development of PAH using mouse model induced by monocrotaline (MCT).

View Article and Find Full Text PDF

Background: Atrial fibrillation (AF) is the most prevalent arrhythmia encountered in clinical practice. Triglyceride glucose index (Tyg), a convenient evaluation variable for insulin resistance, has shown associations with adverse cardiovascular outcomes. However, studies on the Tyg index's predictive value for adverse prognosis in patients with AF without diabetes are lacking.

View Article and Find Full Text PDF

Left atrial shunting devices: why, what, how, and… when?

Heart Fail Rev

January 2025

Department of Cardiology, San Luca Hospital, IRCCS Istituto Auxologico Italiano, Milan, Italy.

Left atrial (LA) hypertension is central in the pathophysiology of heart failure (HF) in general and of HF with preserved ejection fraction (HFpEF) in particular. Despite approved treatments, a number of HF patients continue experiencing disabling symptoms due to LA hypertension, causing pulmonary congestion, pulmonary hypertension, and right heart dysfunction, at rest and/or during exercise. LA decompression therapies, i.

View Article and Find Full Text PDF

The Role of Imaging in Pulmonary Vascular Disease: The Clinician's Perspective.

Radiol Clin North Am

March 2025

Department of Medicine, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8558, USA; Department of Pediatrics, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8558, USA. Electronic address:

Pulmonary vascular diseases, particularly when accompanied by pulmonary hypertension, are complex disorders often requiring multimodal imaging for diagnosis and monitoring. Echocardiography is the primary screening tool for pulmonary hypertension, while cardiac MR imaging (CMR) is used for more detailed characterization and risk stratification in right ventricular failure. Chest computed tomography (CT) is used to detect vascular anomalies and parenchymal lung diseases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!